title: Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
abstract: OBJECTIVE
  To evaluate the feasibility of face-to-face education, a nurse-initiated telephone call, and patient use of medication diaries to support patients' self-reported medication adherence and knowledge of oral chemotherapy.
  
  
  METHODS
  Descriptive, feasibility pilot study.
  
  
  METHODS
  An outpatient oncology unit at a National Cancer Institute-designated comprehensive cancer center.
  
  
  METHODS
  30 patients with gastrointestinal cancer who were prescribed at least one oral chemotherapy agent.
  
  
  METHODS
  Participants received verbal and written education and a nurse-initiated educational telephone call within 72 hours of receiving education. Each was asked to complete a medication diary at home during the first cycle and the eight-item Morisky Medication Adherence Scale (MMAS-8) at the end of the first cycle of oral chemotherapy.
  
  
  METHODS
  Verbal and written education, telephone contacts, drug diary, self-reported medication adherence, and patient knowledge.
  
  
  RESULTS
  Most patients (n = 29) received both verbal and written education, participated by telephone (n = 25), and completed the medication diaries (n = 21) correctly. Seventeen participants documented side effects within the first 72 hours of treatment initiation, with eight participants needing additional assistance with management of side effects. At the end of the first cycle of therapy, MMAS-8 adherence scores were high (X = 7.89, SD = 0.55).
  
  
  CONCLUSIONS
  This study demonstrated the feasibility of a nurse-initiated educational and monitoring protocol for patients with gastrointestinal cancer receiving oral chemotherapy. In addition, the adapted MMAS-8 was a feasible adherence measure.
  
  
  CONCLUSIONS
  Pilot findings support targeted nurse interventions with face-to-face and telephone education to enhance self-monitoring and adherence for patients with gastrointestinal cancer receiving oral chemotherapy.
authors: Center for Gastrointestinal Cancer, Dana-Farber Cancer Institute, Boston, MA, USA. robin_sommers@dfci.harvard.edu
authors: Robin M
authors: RM
authors: Sommers
authors: Kathleen
authors: K
authors: Miller
authors: Donna L
authors: DL
authors: Berry
mesh_terms: D000328:Adult; D000368:Aged; D000553:Ambulatory Care / Q000458:organization & administration*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002173:Cancer Care Facilities / Q000458:organization & administration; D005240:Feasibility Studies; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000451:nursing* / Q000523:psychology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008499:Medical Records; D055118:Medication Adherence; D008875:Middle Aged; D009859:Oncology Nursing / Q000379:methods* / Q000458:organization & administration; D010348:Patient Care Team / Q000458:organization & administration; D010353:Patient Education as Topic / Q000379:methods / Q000458:organization & administration; D010865:Pilot Projects; D015397:Program Evaluation; D013689:Telephone
chemical_list: D000970:Antineoplastic Agents